Skip to content

OKS for the Treatment of Hemispatial Neglect

Optokinetic Stimulation for the Treatment of Hemispatial Neglect - Safety and Efficacy Studies

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03451708
Enrollment
0
Registered
2018-03-02
Start date
2018-05-01
Completion date
2023-03-31
Last updated
2024-06-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neglect, Hemisensory, Neglect, Hemispatial, Neglect, Sensory

Brief summary

Hemispatial neglect is a disorder where the patient has difficulty attending to objects and information in the left side of space, which occurs following strokes to the right side of the brain. This project is designed to help us understand how optokinetic stimulation treats the symptoms of hemispatial neglect.

Interventions

DEVICEOKS

Optokinetic stimulation will be displayed on a see-through liquid crystal display lens placed in front of the subjects.

Sponsors

Johns Hopkins University
CollaboratorOTHER
National Eye Institute (NEI)
CollaboratorNIH
Beth Israel Deaconess Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Masking description

Patient blinded

Eligibility

Sex/Gender
ALL
Age
21 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* Patients with right hemispheric lesions resulting in hemispatial neglect as confirmed by Behavioral Inattention Test or Center of Cancellation Test

Exclusion criteria

* Reduced vision * Documented vestibular disorder

Design outcomes

Primary

MeasureTime frameDescription
Change in Hemispatial neglect scoresAfter 1 hour of OKSPerformance on Center of Cancellation Test
Effect of OKS on visionAfter 1 hour of OKSvisual acuity

Secondary

MeasureTime frameDescription
Changes in secondary hemispatial neglect scoresAfter 1 hour of OKSLine bisection score
Effect of OKS on gaitAfter 1 hour of OKSGait assessment

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026